PHILADELPHIA--(BUSINESS WIRE)--PolyMedix, Inc. (OTC BB: PYMX), an emerging biotech company developing acute care products for infectious diseases and acute cardiovascular disorders based on biomimetics, announced today that Nicholas Landekic, President and CEO will present an overview and update on the company at the Rodman & Renshaw 8th Annual Healthcare Conference being held in New York, November 6-8, 2006. PolyMedix’s presentation is scheduled for Wednesday November 8, 2006, at 11:40 a.m., eastern at the New York Palace Hotel.
